Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate
Business Wire India Samsung Bioepis Co., Ltd. announced today the initiation of Phase 1 clinical trial for SBE303. SBE303 is…
Onlne News For You
Business Wire India Samsung Bioepis Co., Ltd. announced today the initiation of Phase 1 clinical trial for SBE303. SBE303 is…
Business Wire India TestMu AI (Formerly LambdaTest), the world’s first full-stack Agentic AI Quality Engineering platform, today announced a…
New Delhi, April 15 (BNP): Indian equity markets witnessed a sharp upswing, with the BSE Sensex surging over 1,100 points and…
Orbital is building and operating AI data centers in space, using solar power and radiative cooling to remove the energy and cooling constraints that limit…
Business Wire India Sagebrook International School, a premier upcoming IB school in Hyderabad developed in collaboration with Whitgift School, UK,…
Business Wire India GoldenTree Asset Management (“GoldenTree”), a global asset management firm with approximately $70 billion in assets under management,…
Business Wire India Visa (NYSE:V), a global leader in digital payments, today announced it has officially launched its validator node…
Business Wire India Andersen Global continues its regional growth in South Asia with the addition of Andersen in Pakistan as…
Business Wire India Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™, and the leading third-party…
Chandigarh, April 15: Renault India, a wholly owned subsidiary of the French carmaker Renault Group, has commenced nationwide customer deliveries…